Lunxi Liang

1.5k total citations · 1 hit paper
16 papers, 1.0k citations indexed

About

Lunxi Liang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Lunxi Liang has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Oncology. Recurrent topics in Lunxi Liang's work include Helicobacter pylori-related gastroenterology studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Gastroesophageal reflux and treatments (2 papers). Lunxi Liang is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Gastroesophageal reflux and treatments (2 papers). Lunxi Liang collaborates with scholars based in China, Russia and United States. Lunxi Liang's co-authors include Jie Xu, Huanbin Wang, Hubing Shi, Han Yao, Chushu Li, Lan Jiang, Yao Zhang, Jing‐Yuan Fang, Caiyun Fang and Yun Cui and has published in prestigious journals such as Oncogene, Scientific Reports and Nature Chemical Biology.

In The Last Decade

Lunxi Liang

15 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

2019 403 citations Han Yao, Lan Jiang et al. Nature Biomedical Engineering profile →

Peers

Lunxi Liang

ONCOL

IMMUN

PRM

Sara Pensa United Kingdom

Н. В. Литвяков Russia

Johanna Tuomela Finland

Abhijit Aithal United States

Sara Tomei Qatar

Le Li China

Deblina Raychaudhuri India

Dongli Yue China

Isabelle Matte Canada

Lopamudra Das Roy United States

Sara Pensa United Kingdom

Lunxi Liang

544 ×1.1

563 ×1.2

ONCOL

260 ×0.9

IMMUN

215 ×0.8

98 ×0.8

PRM

Citations per year, relative to Lunxi Liang Lunxi Liang (= 1×) peers Sara Pensa

Countries citing papers authored by Lunxi Liang

Since Specialization

Citations

This map shows the geographic impact of Lunxi Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lunxi Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lunxi Liang more than expected).

Fields of papers citing papers by Lunxi Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lunxi Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lunxi Liang. The network helps show where Lunxi Liang may publish in the future.

Co-authorship network of co-authors of Lunxi Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Lunxi Liang. A scholar is included among the top collaborators of Lunxi Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lunxi Liang. Lunxi Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Li, Xinmeng, Xin Yang, Lunxi Liang, et al.. (2025). Helicobacter pylori VacA modulates TRAF1-mediated 4-1BB/NF-kappaB axis to induce host apoptosis and chronic inflammatory damage. Molecular Medicine. 31(1). 317–317.

Liang, Lunxi, Liang Xiao, Ya Zeng, Fen Wang, & Xin Yu. (2025). Establishment and validation of a nomogram for predicting esophagogastric variceal bleeding in patients with liver cirrhosis. World Journal of Gastroenterology. 31(9). 102714–102714. 3 indexed citations

Yang, Xiuyan, Yu Liu, Shanshan Yao, et al.. (2025). Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?. World Journal of Gastroenterology. 31(13). 100863–100863. 3 indexed citations

Liang, Lunxi, et al.. (2025). Identification of lactylation-associated fibroblast subclusters predicting prognosis and cancer immunotherapy response in colon cancer. Gene. 940. 149220–149220. 4 indexed citations

Yao, Shanshan, Ting Cai, Ying Li, et al.. (2024). Helicobacter pylori infection is associated with the risk and phenotypes of cholelithiasis: A multi-center study and meta-analysis. World Journal of Gastroenterology. 30(47). 4991–5006. 2 indexed citations

Liang, Lunxi, et al.. (2024). Bioinformatic Analyses and Integrated Machine Learning to Predict prognosis and therapeutic response Based on E3 Ligase-Related Genes in colon cancer. Journal of Cancer. 15(16). 5376–5395. 16 indexed citations

Yao, Yao, et al.. (2023). Effects of Stool Sample Preservation Methods on Gut Microbiota Biodiversity: New Original Data and Systematic Review with Meta-Analysis. Microbiology Spectrum. 11(3). e0429722–e0429722. 16 indexed citations

Wang, Jilin, Tiantian Sun, Wenyu Su, et al.. (2020). SRSF3 functions as an oncogene in colorectal cancer by regulating the expression of ArhGAP30. Cancer Cell International. 20(1). 120–120. 15 indexed citations

Yao, Han, Lan Jiang, Chushu Li, et al.. (2019). Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nature Biomedical Engineering. 3(4). 306–317. 403 indexed citations breakdown →

10.

Wang, Huanbin, Han Yao, Chushu Li, et al.. (2018). HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity. Nature Chemical Biology. 15(1). 42–50. 249 indexed citations

11.

Qian, Jin, Yueyuan Li, Han Yao, et al.. (2017). ASAP3 regulates microvilli structure in parietal cells and presents intervention target for gastric acidity. Signal Transduction and Targeted Therapy. 2(1). 17003–17003. 2 indexed citations

12.

Wang, Huanbin, Han Yao, Chushu Li, et al.. (2017). PD-L2 expression in colorectal cancer: Independent prognostic effect and targetability by deglycosylation. OncoImmunology. 6(7). e1327494–e1327494. 61 indexed citations

13.

Coillie, Samya Van, Lunxi Liang, Yao Zhang, et al.. (2016). OncoBinder facilitates interpretation of proteomic interaction data by capturing coactivation pairs in cancer. Oncotarget. 7(14). 17608–17615. 9 indexed citations

14.

Liang, Lunxi, et al.. (2015). Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene. 35(12). 1475–1482. 117 indexed citations

15.

Wang, Hui, et al.. (2015). Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers. Oncogene. 35(16). 2011–2019. 67 indexed citations

16.

Liang, Lunxi, Luoyan Ai, Jin Qian, Jing‐Yuan Fang, & Jie Xu. (2015). Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes. Scientific Reports. 5(1). 11763–11763. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact